Kelly J. Kennedy is Director of GoodRx Holdings, Inc.. Currently has a direct ownership of 111,062 shares of GDRX, which is worth approximately $492,004. The most recent transaction as insider was on Jun 03, 2025, when has been sold 57,050 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 111K
105.62% 3M change
291.09% 12M change
Total Value Held $492,004

Kelly J. Kennedy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2025
BUY
Grant, award, or other acquisition
-
57,050 Added 33.94%
111,062 Class A Common Stock
Dec 21 2024
BUY
Exercise of conversion of derivative security
$102,786 $4.44 p/Share
23,150 Added 30.0%
54,012 Class A Common Stock
Jul 08 2024
BUY
Grant, award, or other acquisition
-
2,464 Added 7.39%
30,862 Class A Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
28,398 Added 50.0%
28,398 Class A Common Stock

Also insider at

VITL
Vital Farms, Inc. Consumer Defensive
HNST
Honest Company, Inc. Consumer Cyclical
SATL
Satellogic Inc. Technology
KJK

Kelly J. Kennedy

Director
Los Angeles, CA

Track Institutional and Insider Activities on GDRX

Follow GoodRx Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GDRX shares.

Notify only if

Insider Trading

Get notified when an Good Rx Holdings, Inc. insider buys or sells GDRX shares.

Notify only if

News

Receive news related to GoodRx Holdings, Inc.

Track Activities on GDRX